Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer

Achim A. Jungbluth; Barbara Williamson; Darren Santiago; Dean F. Bajorin; Elisabeth Stockert; Gerd Ritter; Guido Dalbagni; Harry Herr; Lloyd J. Old; Padmanee Sharma; S. Machele Donat; Sacha Gnjatic; Victor E. Reuter; Yao-Tseng Chen

首页> 外文期刊>Cancer immunity >Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer

【24h】

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer

机译：膀胱癌中NY-ESO-1和LAGE-1表达的频率以及新的NY-ESO-1 T细胞表位的证据

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer immunity》 |2003年第2003期|共页
作者
Achim A. Jungbluth; Barbara Williamson; Darren Santiago; Dean F. Bajorin; Elisabeth Stockert; Gerd Ritter; Guido Dalbagni; Harry Herr; Lloyd J. Old; Padmanee Sharma; S. Machele Donat; Sacha Gnjatic; Victor E. Reuter; Yao-Tseng Chen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. CD8~+ T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients [J] . Sacha Gnjatic, Elke Jaeger, Weisan Chen, Proceedings of the National Academy of Sciences of the United States of America . 2002,第18期

机译：NY-ESO-1肽免疫癌症患者后，CD8〜+ T细胞对显性隐性HLA-A2表位的反应
2. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer [J] . GrahJ.J., KatalinicD., JureticA., Tumori. . 2014,第1期

机译：非小细胞肺癌患者癌症/睾丸肿瘤相关抗原（MAGE-A1，MAGE-A3 / 4，NY-ESO-1）的免疫组化表达的临床意义
3. Induction of CD8 T-cell responses restricted to multiple HLA class i alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide [J] . International Journal of Cancer =: Journal International du Cancer . 2013,第2期

机译：通过用20-mer NY-ESO-1f（NY-ESO-1 91-110）肽免疫在癌症患者中诱导限于多个HLA I类等位基因的CD8 T细胞反应
4. Development of a Transient Mammalian Expression Process for the Production of the Cancer Testis Antigen NY-ESO-1 [C] . David L. Hacker, Leonard Cohen, Natalie Muller, General Meeting of European Society of Animal Cell Technology . 2007

机译：开发瞬态哺乳动物表达过程，用于生产癌症抗原NY-ESO-1
5. Cystoscopy and the development of invasive bladder cancer in patients presenting with superficial urinary bladder cancer. [D] . Amos, Charles E., Jr. 2003

机译：膀胱镜检查和浅表性膀胱癌患者的浸润性膀胱癌的发展。
6. CD8+ T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients [O] . Sacha Gnjatic, Elke Jäger, Weisan Chen, 2002

机译：癌症患者NY-ESO-1肽免疫后CD8 + T细胞对显性隐性HLA-A2表位的反应
7. CD8+ T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients [O] . Gnjatic, Sacha, Jäger, Elke, Chen, Weisan, 2002

机译：癌症患者NY-ESO-1肽免疫后，CD8 + T细胞对显性隐性HLA-A2表位的反应

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer

著录项

相似文献

相关主题

期刊订阅